Actively Recruiting

Phase 4
Age: 18Years +
All Genders
NCT07438444

A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

Led by Eli Lilly and Company · Updated on 2026-05-12

344

Participants Needed

21

Research Sites

83 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The main purpose of this study is to measure the safety and efficacy of tirzepatide in adult participants in India who have type 2 diabetes or who have obesity or overweight without type 2 diabetes. Participation in the study will last about 46 weeks.

CONDITIONS

Official Title

A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or older
  • For participants with type 2 diabetes: have had type 2 diabetes for at least one year
  • For participants with type 2 diabetes: be insulin naive
  • For participants with type 2 diabetes: have HbA1c between 7.5% and 10% at screening
  • For participants with type 2 diabetes: have a body mass index (BMI) of 23 kg/m2 or higher
  • For participants with obesity or overweight without type 2 diabetes: have a BMI of 30 kg/m2 or higher, or a BMI of at least 27 kg/m2 with at least one weight-related health condition such as high blood pressure, lipid disorder, obstructive sleep apnea, or heart disease
Not Eligible

You will not qualify if you...

  • For participants with type 2 diabetes: have type 1 diabetes
  • For participants with type 2 diabetes: have had a heart attack, stroke, or hospitalization due to heart failure within 6 months prior to screening
  • For participants with type 2 diabetes: have New York Heart Association Functional Classification Class III or IV congestive heart failure
  • For participants with type 2 diabetes: have morbid obesity and are considered for bariatric surgery or other weight loss procedures
  • For participants with obesity or overweight without type 2 diabetes: have type 1 or type 2 diabetes
  • For participants with obesity or overweight without type 2 diabetes: have had a change in body weight greater than 5 kilograms within 3 months prior to screening
  • For participants with obesity or overweight without type 2 diabetes: have had or plan to have surgical treatment for obesity
  • For participants with obesity or overweight without type 2 diabetes: have had a heart attack, stroke, or hospitalization due to heart failure within 6 months prior to screening
  • For participants with obesity or overweight without type 2 diabetes: have New York Heart Association Functional Classification Class III or IV congestive heart failure
  • For participants with obesity or overweight without type 2 diabetes: have used medications or alternative remedies for weight loss within 3 months prior to screening

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 21 locations

1

B. J. Medical College & Civil Hospital

Ahmedabad, India, 380 016

Actively Recruiting

2

V.S. General Hospital

Ahmedabad, India, 380006

Not Yet Recruiting

3

Gujarat Endocrine Center

Ahmedabad, India, 380052

Actively Recruiting

4

Jawahar Lal Nehru Medical College

Ajmer, India, 305001

Not Yet Recruiting

5

Motilal Nehru Medical College Hospital

Allahābād, India, 211002

Actively Recruiting

6

Lifecare Hospital and Research Centre

Bengaluru, India, 560092

Actively Recruiting

7

AIIMS, Bhubaneshwar

Bhubaneswar, India, 751019

Not Yet Recruiting

8

Sri Ramachandra MedicaL College & Research Institute

Chennai, India, 600116

Actively Recruiting

9

Kovai Diabetes Speciality Center and Hospital

Coimbatore, India, 641009

Actively Recruiting

10

Apollo Excelcare Hospital

Guwahati, India, 781033

Actively Recruiting

11

Osmania Medical College & Hospital

Hyderabad, India, 500012

Actively Recruiting

12

Eternal Heart Care Center and Research Institute

Jaipur, India, 302017

Actively Recruiting

13

K care Hospital

Kanpur, India, 208001

Actively Recruiting

14

Brij Medical Centre Private Limited

Kanpur, India, 208020

Not Yet Recruiting

15

ILS Hospitals

Kolkata, India, 700064

Actively Recruiting

16

Government Medical College, Kozhikode

Kozhikode, India, 673008

Actively Recruiting

17

Wockhardt Hospitals

Mumbai, India, 400011

Not Yet Recruiting

18

Shri Krishna Hrudayalaya & Critical Care Centre

Nagpur, India, 440012

Actively Recruiting

19

Sahyadri Super Speciality Hospital

Pune, India, 411004

Actively Recruiting

20

All India Institute of Medical Sciences

Raipur, India, 492099

Not Yet Recruiting

21

King George Hospital, Andhra Medical College

Visakhapatnam, India, 530002

Not Yet Recruiting

Loading map...

Research Team

T

Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or

CONTACT

P

Physicians interested in becoming principal investigators please contact

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here